Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Prevalence and Predictors of Renal Impairment Among Patients with Multiple Myeloma (MM): An Analysis of Oncology Clinic Electronic Health Records Linked to Commercial Claims in the United States

Geoffrey Block, MD, Alan Fu, PhD MPH, Sally Wade, MPH, Renee Jaramillo, Sumita Bhatta, MD, Leon Raskin, PhD, Rohini K Hernandez, PhD

Blood (2018) 132 (Supplement 1): 5657.

https://doi.org/10.1182/blood-2018-99-115456

Published: 2018

Journal Articles

Patterns and Predictors of Initiation of Intravenous Bisphosphonates Among Patients with Multiple Myeloma in the United States

Leah J McGrath, PhD, Rohini K Hernandez, PhD, Robert Overman, PhD, Diane Reams, Pharm.D., MPH, Alexander Liede, MSc, PhD, M. Alan Brookhart, PhD

Blood (2017) 130 (Supplement 1): 534.

https://doi.org/10.1182/blood.V130.Suppl_1.534.534

Published: 2017

Journal Articles

Multiple Myeloma Patients and Risk of Skeletal Related Events - Real-World Evidence in US Oncology Clinics

Sumita Bhatta, MD, Lori Cyprien, Rafael Fonseca, MD, Rohini K Hernandez, PhD, Christopher Kim, PhD

Blood (2017) 130 (Supplement 1): 2171.

https://doi.org/10.1182/blood.V130.Suppl_1.2171.2171

Published: 2017

Journal Articles

Bone Targeting Agent Treatment Patterns Among Patients with Multiple Myeloma Treated at Oncology Clinics Across the United States: Observations from Real-World Data

Christopher Kim, Rohini K. Hernandez, PhD, Paul C Cheng, MD PhD, Jeremy Smith, Lori Cyprien, Alexander Liede, BSc, MSc, PhD

Blood (2016) 128 (22): 2364.

https://doi.org/10.1182/blood.V128.22.2364.2364

Published: 2016

Journal Articles

Utilization Patterns of Bone-Targeting Agents Among Patients with Multiple Myeloma: Analysis of Real-World Data

Yi Qian, PhD, Debajyoti Bhowmik, B.Pharm, PhD, Nandita Kachru, MS, Rohini K. Hernandez, PhD, Paul Cheng, MD PhD, Alexander Liede, BSc, MSc, PhD

Blood (2015) 126 (23): 4501.

https://doi.org/10.1182/blood.V126.23.4501.4501

Published: 2015

NARROW

Prevalence and Predictors of Renal Impairment Among Patients with Multiple Myeloma (MM): An Analysis of Oncology Clinic Electronic Health Records Linked to Commercial Claims in the United States

Patterns and Predictors of Initiation of Intravenous Bisphosphonates Among Patients with Multiple Myeloma in the United States

Multiple Myeloma Patients and Risk of Skeletal Related Events - Real-World Evidence in US Oncology Clinics

Bone Targeting Agent Treatment Patterns Among Patients with Multiple Myeloma Treated at Oncology Clinics Across the United States: Observations from Real-World Data

Utilization Patterns of Bone-Targeting Agents Among Patients with Multiple Myeloma: Analysis of Real-World Data

Email alerts

ASH Publications

American Society of Hematology

Prevalence and Predictors of Renal Impairment Among Patients with Multiple Myeloma (MM): An Analysis of Oncology Clinic Electronic Health Records Linked to Commercial Claims in the United States

Patterns and Predictors of Initiation of Intravenous Bisphosphonates Among Patients with Multiple Myeloma in the United States

Multiple Myeloma Patients and Risk of Skeletal Related Events - Real-World Evidence in US Oncology Clinics

Bone Targeting Agent Treatment Patterns Among Patients with Multiple Myeloma Treated at Oncology Clinics Across the United States: Observations from Real-World Data

Utilization Patterns of Bone-Targeting Agents Among Patients with Multiple Myeloma: Analysis of Real-World Data

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only